BEIJING–(BUSINESS WIRE)–#Antibody–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) (HKEX: 02315), today announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (“Janssen”). Under the agreement, Biocytogen grants Janssen and its affiliates a non-exclusive worldwide license to use Biocytogen’s proprietary RenLite™ platform and underlying intellectual … [Read more…]

GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8008, an antibody-drug conjugate (ADC) that targets Trop2. The multicenter, open-label Phase 1 clinical study in patients with advanced solid tumors aims to evaluate the safety and tolerability of BAT8008. Key … [Read more…]

Akston has reclaimed all commercial rights to AKS-452, its room temperature stable COVID-19 vaccine Akston is continuing its progress to secure Emergency Use Authorization (EUA) in India and has begun working with a new CDMO to produce AKS-452   BEVERLY, Mass. and BANGALORE, India–(BUSINESS WIRE)–#VIE–Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, … [Read more…]

TOKYO–(BUSINESS WIRE)–The Japan natto cooperative society federation (Arakawa-ku, Tokyo; Chairman: Yoshihiro Noro) has launched the Chinese version of its new website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” to promote the power of natto, a traditional Japanese food that has supported Japanese people’s health, to the world. • “Natto … [Read more…]

TOKYO–(BUSINESS WIRE)–The Japan natto cooperative society federation (Arakawa-ku, Tokyo; Chairman: Yoshihiro Noro) has launched its new website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” to promote the power of natto, a traditional Japanese food that has supported Japanese people’s health, to the world. • “Natto Power” official English website … [Read more…]

MEXICO CITY–(BUSINESS WIRE)–#Mexico–Activists and public health experts in Mexico demand that officials of the Mexican Ministry of Health (SSA) and the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) authorize the use of monkeypox (mpox) vaccines in the country. “Despite the fact that mpox was declared a Public Health Emergency of International Concern by … [Read more…]

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), a leading provider of cloud revenue management solutions for life sciences and high tech companies, announced today that it intends to offer, subject to market conditions and other factors, $220.0 million aggregate principal amount of convertible senior notes due 2028 in a private placement to persons reasonably … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“Miravo” or the “Company”) is pleased to announce that, at today’s special meeting of shareholders (the “Meeting”), its shareholders (“Shareholders”) voted in favour of a special resolution to approve the previously announced plan of arrangement (the “Arrangement”) pursuant to which, among other things, Searchlight Pharma … [Read more…]

2022 was a year of transformation and change: reported $412.5 million in total revenue for the year ended December 31, 2022; reported net income of $124.3 million ($1.90 per fully diluted share) for 2022 compared to net loss of $211.8 million in 2021; reported $492.2 million in cash resources as of December 31, 2022, with … [Read more…]

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2022, and provided its financial outlook for 2023. Fourth Quarter 2022 Highlights Revenue of $282 million, a … [Read more…]